Skip to content
MedBiz Pro

e-mail: info@medbizpro.com
  • News
  • Blog Zone
  • Contact
  • sr
MedBiz Pro > Oglasi > Opremljen lokal za apoteku, na prodaju

Opremljen lokal za apoteku, na prodaju

Posted on 29/06/2018 by Mila

Opremljen lokal za apoteku, ima toalet, kancelariju. U suterenu se nalaze dve prostorije, magacin i toalet. Visina plafona u prizemlju 5m. Su+pr/5 spratova. Više informacija:

http://www.kacalazarevic.com/property-13569

Posted in Oglasi
Post navigation
Mediterranean Diet Scores Again for Heart Health →
← Diplomirani farmaceut, Beograd

News

  • New AI tool predicts breast cancer risk using repeated 3D mammograms
    on 10/09/2026 at 12:18 pm

    An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that uses only the most recent, single 3D mammogram, as well as an AI model that analyzes 2D mammograms, a new study shows.

  • Symptomless liver condition linked to heart and kidney disease
    on 10/09/2026 at 11:49 am

    A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of Manchester and Northern Care Alliance NHS Foundation Trust researchers.

  • Compassion and connection at heart of suicide prevention
    on 10/09/2026 at 10:47 am

    Compassion, trust and person-centerd care must be at the heart of supporting people experiencing suicidal distress, according to a leading Adelaide University suicide prevention expert.

  • Evaluating new approaches for rare disease research
    on 10/09/2026 at 9:43 am

    Marcel Nelen discusses his team’s early evaluation of a new workflow for rare disease genomics.

  • Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis
    on 10/09/2026 at 7:35 am

    Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day.

  • Nighttime light exposure may alter heart structure and function
    on 10/09/2026 at 7:16 am

    Exposure to light during the nighttime is linked to important and potentially harmful changes to the structure and function of the heart, according to a study of more than 11,000 people published in the European Heart Journal today (Thursday).

  • Tizanidine looked promising early in a migraine trial, but the benefit did not last
    on 10/09/2026 at 4:44 am

    A randomized, double-blind, placebo-controlled trial found that low-dose tizanidine did not provide sustained reductions in headache burden over 12 weeks in people with episodic migraine, despite a transient improvement with the 1 mg dose at week 4. Exploratory analyses suggested that smoking and sex may influence tizanidine exposure, while sex-specific efficacy signals remained hypothesis-generating and require confirmation.

  • Rentosertib shifts multiple proteomic aging clocks toward younger age profiles in IPF trial
    on 10/09/2026 at 4:24 am

    Researchers applied six proteomic aging clocks to serum samples from a phase 2a trial of rentosertib in people with idiopathic pulmonary fibrosis and found treatment-associated shifts toward younger predicted biological-age profiles, particularly with the 30 mg twice-daily regimen. Additional proteomic analyses linked treatment to changes in senescence, metabolism, growth-factor signaling, and fibrosis-related pathways, although the study could not determine whether these effects reflected genuine geroprotection rather than disease modification.

  • Bruker advances whole-organism 3D imaging with enhanced tissue-clearing workflows
    on 10/09/2026 at 4:16 am

    Bruker Corporation today announced a strategic collaboration with Translucence Biosystems, Inc., a leading provider of tissue‑clearing solutions, to expand its workflow for cleared tissue imaging.

  • Gut microbiome may reveal inflammation and future disease risk better than age
    on 10/09/2026 at 3:59 am

    Gut microbiota composition explained more variation than chronological age in nearly all inflammatory cytokines and most physiological measures examined, with specific microbial profiles linked to markedly different patterns of inflammation across adulthood. People with the Bacteroides 2 enterotype showed an inflammaging-like profile decades earlier than other groups and had a higher risk of subsequent disease, while a high-diversity microbiota profile was associated with lower inflammation and reduced disease incidence.

  • Longitudinal recovery trajectories in spine oncology following spine surgery using patient-reported outcomes (PROs)
    on 10/09/2026 at 12:00 am
  • Bioactive ultrasound preserves periosteal vascular architecture during mechanical unloading
    on 10/09/2026 at 12:00 am
  • Pre-treatment prediction of EBV-DNA status in nasopharyngeal carcinoma using CE-T1WI radiomics combined with clinical features: a multi-sequence MRI radiomics study
    on 10/09/2026 at 12:00 am
  • The Value Cube: translating clinical benefit into realizable value in global oncology
    on 10/09/2026 at 12:00 am
  • Establishment and internal-external validation of a clinical-adipometric prognostic model for heart failure with preserved ejection fraction
    on 10/09/2026 at 12:00 am
  • Nceh1 protects against myocardial ischemia/reperfusion injury by suppressing oxidative stress and apoptosis
    on 10/09/2026 at 12:00 am
  • Virtual reality patient education before radiation therapy: effects on knowledge and psychological outcomes
    on 10/09/2026 at 12:00 am
  • Uncertainty-aware triage of microsatellite instability status in colorectal cancer from H&E-stained whole-slide images
    on 10/09/2026 at 12:00 am
  • Prior ayahuasca experience is associated with improved mental health: observational data from ritualistic settings
    on 10/09/2026 at 12:00 am
  • Addressing the challenges of remote diagnostics: diagnostic yield of point-of-care nucleic acid amplification tests (NAAT) versus conventional culture for the detection of skin ulcer pathogens
    on 10/09/2026 at 12:00 am
Theme by Out the Box
  • News
  • Blog Zone
  • Contact